SCHEMBL25118630

SCHEMBL25118630

COCc1ccc(-c2ccc(-c3cc(C(=O)O)c4cc(F)ccc4n3)nc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 7/20 0.57
▸ EIF4A1 P60842 5/20 0.52
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ GAA P10253 1/20 0.51
▸ PLA2G2A P14555 2/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ PTGES O14684 1/20 0.43
▸ ALOX5 P09917 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ HIF1A Q16665 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23590110 0.91 DHODH (0.58) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL23590321 0.90 DHODH (0.70) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL29617667 0.90 DHODH (0.70) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL23590118 0.90 DHODH (0.55) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL26075654 0.90 KDM4E (0.53) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL26074552 0.89 EIF4A1 (0.50) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL25118616 0.88 DHODH (0.46) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL23590222 0.87 PLA2G2A (0.67) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL23590115 0.86 DHODH (0.56) DHODHEIF4A1MEN1KMT2AALDH1A1
SCHEMBL23590111 0.85 DHODH (0.56) DHODHEIF4A1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed
US-20230109418-A1 COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE OHIO STATE INNOVATION FOUNDATION (US) 2023-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885EIF4A1 4791/4885MEN1 2373/4885
US-20230109418-A1 COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE DHODH, DDO, DLD DHODH 1/4885EIF4A1 2943/4885MEN1 1960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback